Nebraska Center for Nanomedicine- Nanomaterial Characterization Core
内布拉斯加州纳米医学中心 - 纳米材料表征核心
基本信息
- 批准号:10163872
- 负责人:
- 金额:$ 7.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdministratorAdvertisingAdvisory CommitteesApplications GrantsAreaBasic ScienceBioinformaticsBiological AssayBiological SciencesBiologyBiometryBiotechnologyCenters of Research ExcellenceClinicalCollaborationsCommunicationCore FacilityDevelopmentDisciplineDiseaseDrug Delivery SystemsEarly DiagnosisEffectivenessEngineeringEnsureEnvironmentEquipmentEvaluationFosteringFundingGene DeliveryGenerationsGoalsGrantGrowthInterdisciplinary StudyLeadershipLifeMedicineMentorsMethodsMissionModernizationMonitorNanotechnologyNebraskaPerformancePharmacologyPhasePilot ProjectsPositioning AttributePropertyRecombinant DNAReproducibilityResearchResearch PersonnelResearch Project GrantsResourcesSafetyScienceScientistServicesSourceStructureSupport GroupsTechniquesTechnologyTherapeuticTrainingbasebioimagingdata sharingdesignimprovedinnovationmaterials sciencemedical specialtiesmeetingsmembernanomaterialsnanomedicinenanosystemsnovelnovel strategiesoperationoutreachpreservationprogramsside effectskills trainingsuccesssynergismtherapeutic proteintooltumorvoucher
项目摘要
ABSTRACT
The Nebraska Center for Nanomedicine (NCN), a Center of Biomedical Research Excellence
(COBRE), integrates and supports interdisciplinary, multi-project, multi-departmental research in the
field of nanomedicine. The Administrative Core serves as a centralized governing source for the
COBRE NCN and provides a framework for supporting the unique features of the NCN: collaborative
research environment, mentoring junior investigators, access to state-of-the-art core facilities and
organization of the Center activities. The Administrative Core is led by the Center Director and
includes an Executive Committee, a Center Administrator, a Scientific and Professional Development
Council, and a Biostatistics/Bioinformatics support group. The Executive Committee consisting of the
Center Director, Core Directors, and Coordinator of Scientific and Professional Development Council,
will monitor research progress and core performance, review research initiatives and coordinate
activities within the Center. The Internal Advisory Committee (IAC) and External Advisory Committees
(EAC) will continue to review Center activities and guide the Center. The Administrative Core will
accomplish the following specific aims in Phase III: 1) Provide scientific leadership and an
administrative structure that fosters communication, collaboration and synergy among NCN members;
2) Sustain core resources; and 3) Ensure operational management of the NCN. To achieve these
goals, the Administrative Core will support monthly work-in-progress meetings, seminars, and annual
Center review meetings, facilitate the operations of the core facilities and promote their use through a
voucher program; foster research collaborations and growth of the Center by overseeing the Pilot
Projects Program and mentoring programs. In addition, the Administrative Core will coordinate the
activities of the Scientific and Professional Development Council, which will participate in the review
and selection of pilot projects, promote success of junior investigators and guide investigators along
the path to develop well-constructed collaborative grant proposals.
RELEVANCE
The interactions and discussions that occur within our Center facilitate generation of new ideas and
new approaches. The research driven by innovators across disciplines such as material science,
engineering, biology and medicine stand to impact nearly every medical specialty and unveil novel
ways to improve the quality and extend the duration of life.
抽象的
内布拉斯加州纳米医学中心 (NCN),生物医学卓越研究中心
(COBRE),整合并支持跨学科、多项目、多部门的研究
纳米医学领域。行政核心作为中央管理源
COBRE NCN 并提供了支持 NCN 独特功能的框架:协作
研究环境、指导初级研究人员、使用最先进的核心设施以及
中心活动的组织。行政核心由中心主任领导
包括执行委员会、中心管理员、科学和专业发展部门
理事会和生物统计学/生物信息学支持小组。执行委员会由
中心主任、核心主任、科学与专业发展委员会协调员,
将监测研究进展和核心绩效,审查研究计划并协调
中心内的活动。内部咨询委员会 (IAC) 和外部咨询委员会
(EAC) 将继续审查中心的活动并指导中心。行政核心将
在第三阶段完成以下具体目标: 1)提供科学领导和
促进 NCN 成员之间沟通、协作和协同作用的行政结构;
2)维持核心资源; 3) 确保 NCN 的运营管理。为了实现这些
目标,行政核心将支持每月的进展中会议、研讨会和年度会议
中心审查会议,促进核心设施的运营并通过
优惠券计划;通过监督试点项目促进研究合作和中心的发展
项目计划和指导计划。此外,行政核心将协调
科学和专业发展委员会的活动,该委员会将参加审查
和试点项目的选择,促进初级研究者的成功并指导研究者
制定结构良好的协作拨款提案的途径。
关联
我们中心内发生的互动和讨论促进了新想法的产生和
新方法。由材料科学等跨学科创新者推动的研究,
工程学、生物学和医学将影响几乎所有医学专业并推出新颖的
提高质量和延长寿命的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Oupicky其他文献
David Oupicky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Oupicky', 18)}}的其他基金
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
基于氯喹的聚合物颗粒作为口服不可吸收治疗炎症性肠病
- 批准号:
10356892 - 财政年份:2020
- 资助金额:
$ 7.63万 - 项目类别:
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
基于氯喹的聚合物颗粒作为口服不可吸收治疗炎症性肠病
- 批准号:
10652269 - 财政年份:2020
- 资助金额:
$ 7.63万 - 项目类别:
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
开发联合 microRNA 治疗酒精相关性肝病的递送方法
- 批准号:
10207371 - 财政年份:2019
- 资助金额:
$ 7.63万 - 项目类别:
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
开发联合 microRNA 治疗酒精相关性肝病的递送方法
- 批准号:
9758400 - 财政年份:2019
- 资助金额:
$ 7.63万 - 项目类别:
Nebraska Center for Nanomedicine- Pilot Projects
内布拉斯加州纳米医学中心 - 试点项目
- 批准号:
10163874 - 财政年份:2018
- 资助金额:
$ 7.63万 - 项目类别:
Development of siRNA conjugates for combination treatment of acute kidney injury
开发用于联合治疗急性肾损伤的 siRNA 缀合物
- 批准号:
9789273 - 财政年份:2018
- 资助金额:
$ 7.63万 - 项目类别:
Development of siRNA conjugates for combination treatment of acute kidney injury
开发用于联合治疗急性肾损伤的 siRNA 缀合物
- 批准号:
10213017 - 财政年份:2018
- 资助金额:
$ 7.63万 - 项目类别:
Development of siRNA conjugates for combination treatment of acute kidney injury
开发用于联合治疗急性肾损伤的 siRNA 缀合物
- 批准号:
10434824 - 财政年份:2018
- 资助金额:
$ 7.63万 - 项目类别:
Development of siRNA conjugates for combination treatment of acute kidney injury
开发用于联合治疗急性肾损伤的 siRNA 缀合物
- 批准号:
9976515 - 财政年份:2018
- 资助金额:
$ 7.63万 - 项目类别:
相似国自然基金
小型类人猿合唱节奏的功能假说——宣
示社会关系(Social bond
advertising) ——验证研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
相似海外基金
SaTC: CORE: Medium: Increasing user autonomy and advertiser and platform responsibility in online advertising
SaTC:核心:中:增加在线广告中的用户自主权以及广告商和平台责任
- 批准号:
2318290 - 财政年份:2024
- 资助金额:
$ 7.63万 - 项目类别:
Continuing Grant
Marketing meaninglessness: critical anthropology of transnational advertising agencies
营销无意义:跨国广告公司的批判人类学
- 批准号:
2724869 - 财政年份:2024
- 资助金额:
$ 7.63万 - 项目类别:
Studentship
Collaborative Research: SaTC: CORE: Medium: Understanding and Combatting Impersonation Attacks and Data Leakage in Online Advertising
协作研究:SaTC:核心:媒介:理解和打击在线广告中的冒充攻击和数据泄露
- 批准号:
2247516 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Continuing Grant
Innovation in Manufacturing to benefit the Marketing & Advertising Industry
制造创新有利于营销
- 批准号:
10064566 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Collaborative R&D
The Impact of Programmatic Advertising on Market Competition
程序化广告对市场竞争的影响
- 批准号:
23K18786 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
A Dynamic Analysis of Advertising Interactive Techniques to Gain the Consumer Engagement
获得消费者参与的广告互动技术的动态分析
- 批准号:
23K01642 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Enabling profitable digital advertising for British SMEs with AI-powered multichannel ads brokerage service
通过人工智能驱动的多渠道广告经纪服务,为英国中小企业实现盈利的数字广告
- 批准号:
10070962 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Collaborative R&D
Cross-Platform Advertising Accountability
跨平台广告责任
- 批准号:
10071299 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Collaborative R&D
Improving the accountability of dark advertising on digital platforms
提高数字平台上暗广告的问责制
- 批准号:
IE230100647 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Early Career Industry Fellowships
An AI/ML-powered insight and improvement tool to help bricks and mortar Mission-Led Business (MLBs) to improve advertising, marketing and business performance
一款由 AI/ML 驱动的洞察和改进工具,可帮助实体任务主导型企业 (MLB) 改善广告、营销和业务绩效
- 批准号:
10067255 - 财政年份:2023
- 资助金额:
$ 7.63万 - 项目类别:
Collaborative R&D














{{item.name}}会员




